Fagron N.V.
A global pharmaceutical compounding company focused on personalized medicine.
FAGR | BR
Overview
Corporate Details
- ISIN(s):
- BE0003874915
- LEI:
- 549300TRKRUFK2RRG779
- Country:
- Belgium
- Address:
- Venecoweg 20A, 9810 Nazareth
- Website:
- https://fagron.com/
- Sector:
- Manufacturing
Description
Fagron N.V. is a global company active in pharmaceutical compounding, focusing on the delivery of personalized medicine. The company optimizes and innovates compounding to widen the therapeutic options for prescribers worldwide. Fagron develops, markets, and distributes pharmaceutical raw materials, equipment, and specially formulated vehicles and bases, such as the Pentravan® transdermal base and the SyrSpend® range of oral suspending vehicles. Its primary customers are hospitals, pharmacies, and clinics. The company also operates in the field of genomics to further support personalized healthcare solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-06-06 19:00 |
250606 - Press release increase share capital 6 June 2025.pdf
|
English | 93.1 KB | ||
| 2025-06-06 19:00 |
250606 - Persbericht verhoging kapitaal 6 juni 2025.pdf
|
Dutch | 94.7 KB | ||
| 2025-04-11 08:00 |
250411_Fagron publishes agenda for 2025 annual shareholders meeting.pdf
|
English | 79.6 KB | ||
| 2025-04-11 08:00 |
12 May 2025 - Convocation AGM 12 May 2025.pdf
|
English | 157.9 KB | ||
| 2025-04-11 08:00 |
12 mei 2025 - Volmacht AVA 12 mei 2025.pdf
|
Dutch | 299.5 KB | ||
| 2025-04-11 08:00 |
12 May 2025 - Proxy AGM 12 May 2025.pdf
|
English | 287.5 KB | ||
| 2025-04-11 08:00 |
12 mei 2025 - Oproeping AVA 12 mei 2025.pdf
|
Dutch | 243.6 KB | ||
| 2025-04-11 08:00 |
250411_Fagron publiceert agenda jaarlijkse aandeelhoudersvergadering 2025.pdf
|
Dutch | 83.2 KB | ||
| 2025-04-10 07:00 |
Record first-quarter revenue of €239 million, reflecting 14% topline growth .pdf
|
English | 229.8 KB | ||
| 2025-04-10 07:00 |
Recordomzet van € 239 miljoen in het eerste kwartaal, wat een omzetgroei van 14…
|
Dutch | 226.1 KB | ||
| 2025-04-10 07:00 |
Record first-quarter revenue of €239 million, reflecting 14% topline growth .pdf
|
English | 229.8 KB | ||
| 2025-04-10 07:00 |
Recordomzet van € 239 miljoen in het eerste kwartaal, wat een omzetgroei van 14…
|
Dutch | 226.1 KB | ||
| 2025-03-06 07:00 |
250306_Fagron publishes annual report 2024.pdf
|
English | 92.5 KB | ||
| 2025-03-06 07:00 |
Annual-report-2024.pdf
|
English | 11.3 MB | ||
| 2025-03-06 07:00 |
Jaarverslag-2024.pdf
|
Dutch | 11.6 MB |
Automate Your Workflow. Get a real-time feed of all Fagron N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Fagron N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Fagron N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-23 | Pulido Andrew | Executive member | Sell | 85,000 | 1,803,351.50 EUR |
| 2025-05-22 | Pulido Andrew | Executive member | Buy | 85,000 | 1,617,550.00 EUR |
| 2025-05-02 | De Jong Cornelia Neeltje | Board | Sell | 12,689 | 263,834.55 EUR |
| 2025-04-30 | De Jong Cornelia Neeltje | Board | Sell | 229 | 4,660.15 EUR |
| 2025-04-29 | De Jong Cornelia Neeltje | Board | Sell | 10,000 | 201,500.00 EUR |
| 2025-03-28 | J. Verlinden | Other | Buy | 24,551 | 453,702.48 EUR |
| 2025-03-28 | J. Verlinden | Other | Sell | 17,930 | 344,047.56 EUR |
| 2025-03-27 | Padilla Rafael | Board | Buy | 78,469 | 1,450,107.12 EUR |
| 2025-03-27 | De Jong Cornelia Neeltje | Board | Buy | 45,418 | 839,324.64 EUR |
| 2025-02-21 | Bakker Vera | Executive member | Buy | 773 | 15,000.00 EUR |
Peer Companies
